ETF Managers Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $88.6K | Buy |
26,460
+5,695
| +27% | +$19.1K | ﹤0.01% | 645 |
|
|
2022
Q4 | $99.9K | Sell |
20,765
-3,804
| -15% | -$18.3K | ﹤0.01% | 491 |
|
|
2022
Q3 | $140K | Sell |
24,569
-1,735
| -7% | -$9.89K | ﹤0.01% | 632 |
|
|
2022
Q2 | $192K | Buy |
26,304
+1,059
| +4% | +$7.73K | 0.01% | 646 |
|
|
2022
Q1 | $179K | Buy |
25,245
+129
| +0.5% | +$915 | ﹤0.01% | 607 |
|
|
2021
Q4 | $227K | Sell |
25,116
-5,109
| -17% | -$46.2K | ﹤0.01% | 607 |
|
|
2021
Q3 | $971K | Buy |
30,225
+5,822
| +24% | +$187K | 0.02% | 274 |
|
|
2021
Q2 | $596K | Sell |
24,403
-909
| -4% | -$22.2K | 0.01% | 453 |
|
|
2021
Q1 | $1.42M | Sell |
25,312
-13,231
| -34% | -$744K | 0.03% | 233 |
|
|
2020
Q4 | $1.61M | Buy |
+38,543
| New | +$1.61M | 0.04% | 212 |
|